Skip to main content

Karyopharm Therapeutics Inc.

KPTI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001503802

In the last 90 days, Karyopharm Therapeutics Inc. insiders filed 0 open-market purchases and 2 sales; 96 institutions reported holding it in 13F filings for Q2 2026, worth $206.8M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Karyopharm Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
2 filings
2 insiders, $1.38K in total
Insiders trading
2
Net value
−$1.38K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Karyopharm Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Karyopharm Therapeutics Inc.
NameTitleLast reported holdingLast filingFilings, past year
Abate KristinChief Accounting Officer23,782Sep 2, 20267
Poulton StuartEVP, Chief Development Officer94,632Jul 30, 20266
Bohlin Garen GDirector18,517May 26, 20261
Pakianathan DeepikaDirector15,508May 26, 20261
Greene Barry EDirector16,415May 26, 20261
Schor ChenDirector15,508May 26, 20261
Oliger Christy J.Director15,508May 26, 20261
Su ZhenDirector15,508May 26, 20261
Paulson Richard A.President and CEO269,747May 15, 20264
Rangwala ReshmaEVP & Chief Medical Officer56,829May 15, 20264
Mano MichaelEVP, CLO&Secretary94,398May 15, 20264
Cheng Sohanya RoshanEVP & Chief Commercial Officer107,940May 15, 20264
Macomber LoriEVP, CFO & Treasurer85,105Feb 4, 20263
Mirza Mansoor RazaDirector–May 29, 20250
Mason MichaelEVP, CFO & Treasurer391,054Sep 5, 20240
Honig PeterDirector–May 25, 20230
Mitchener StephenSVP, Chief Business Officer128,313Mar 2, 20230
Shacham SharonChief Scientific Officer958,131Mar 31, 20220
Kauffman MichaelDirector898,131IndirectMar 2, 20220
Frenkel RanEVP, Chief Dev. Officer168,290Mar 2, 20220
Shah JatinEVP, Chief Medical Officer129,450Feb 22, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 3, 2021 (view filing)Dec 21 dayMitchener StephenSVP, Chief Business OfficerSSale−499$6.69−$3.34K−13.1%3.30K after
Feb 9, 2022 (view filing)Feb 72 daysShacham SharonChief Scientific OfficerSSale−6.71K$9.86−$66.1K−0.7%913.4K after
Feb 9, 2022 (view filing)Feb 72 daysShacham SharonChief Scientific OfficerSSale−6.76K$9.86−$66.7K−0.9%708.1K after
Feb 9, 2022 (view filing)Feb 72 daysKauffman MichaelDirectorSSale−6.76K$9.86−$66.7K−0.9%708.1K afterDuplicate filing
Feb 9, 2022 (view filing)Feb 72 daysKauffman MichaelDirectorSSale−6.71K$9.86−$66.1K−0.7%913.4K afterDuplicate filing
Feb 9, 2022 (view filing)Feb 72 daysMason MichaelEVP, CFO & TreasurerSSale−3.95K$9.86−$38.9K−6.9%53.3K after
Feb 9, 2022 (view filing)Feb 72 daysFrenkel RanEVP, Chief Dev. OfficerSSale−1.99K$9.86−$19.6K−1.9%104.6K after
Feb 9, 2022 (view filing)Feb 72 daysShah JatinEVP, Chief Medical OfficerSSale−1.70K$9.86−$16.8K−1.3%130.8K after
Feb 22, 2022 (view filing)Feb 175 daysKauffman MichaelDirectorSSale−9.08K$12.12−$110.0K−1.3%699.0K after
Feb 22, 2022 (view filing)Feb 175 daysKauffman MichaelDirectorSSale−9.09K$12.12−$110.1K−1.0%904.4K after
Feb 22, 2022 (view filing)Feb 175 daysShacham SharonChief Scientific OfficerSSale−9.09K$12.12−$110.1K−1.0%904.4K afterDuplicate filing
Feb 22, 2022 (view filing)Feb 175 daysShacham SharonChief Scientific OfficerSSale−9.08K$12.12−$110.0K−1.3%699.0K afterDuplicate filing
Feb 22, 2022 (view filing)Feb 175 daysFrenkel RanEVP, Chief Dev. OfficerSSale−2.93K$12.12−$35.5K−2.8%101.7K after
Feb 22, 2022 (view filing)Feb 175 daysShah JatinEVP, Chief Medical OfficerSSale−1.31K$12.12−$15.8K−1.0%129.4K after
Mar 2, 2022 (view filing)Feb 282 daysKauffman MichaelDirectorSSale−6.23K$10.24−$63.8K−0.9%713.8K after
Mar 2, 2022 (view filing)Feb 282 daysKauffman MichaelDirectorSSale−6.23K$10.24−$63.8K−0.7%898.1K after
Mar 2, 2022 (view filing)Feb 282 daysShacham SharonChief Scientific OfficerSSale−6.23K$10.24−$63.8K−0.7%898.1K afterDuplicate filing
Mar 2, 2022 (view filing)Feb 282 daysShacham SharonChief Scientific OfficerSSale−6.23K$10.24−$63.8K−0.9%713.8K afterDuplicate filing
Mar 2, 2022 (view filing)Feb 282 daysMason MichaelEVP, CFO & TreasurerSSale−2.40K$10.24−$24.6K−1.7%139.1K after
Mar 2, 2022 (view filing)Feb 282 daysFrenkel RanEVP, Chief Dev. OfficerSSale−1.66K$10.24−$17.0K−1.0%168.3K after
May 5, 2022 (view filing)May 41 dayPaulson Richard A.President and CEOSSale−28.5K$6.23−$177.6K−4.3%633.4K after2 lots
Jun 6, 2022 (view filing)Jun 33 daysMason MichaelEVP, CFO, TreasurerSSale−601$6.04−$3.63K−0.4%138.5K after2 lots
Jun 8, 2022 (view filing)Jun 71 dayPaulson Richard A.President and CEOSSale−2.54K$5.76−$14.6K−0.4%630.9K after
Jun 10, 2022 (view filing)Jun 8-102 daysPakianathan DeepikaDirectorSSale−538.8K$6.37−$3.43M−97.0%16.7K after6 lots
Jun 14, 2022 (view filing)Jun 131 dayCheng Sohanya RoshanChief Commercial OfficerSSale−1.55K$5.21−$8.08K−1.7%89.9K after2 lots
Jul 11, 2022 (view filing)Jul 83 daysPaulson Richard A.President and CEOSSale−2.12K$5.18−$11.0K−0.3%628.8K after
Aug 5, 2022 (view filing)Aug 41 dayPaulson Richard A.President and CEOSSale−2.31K$4.48−$10.4K−0.4%626.5K after
Sep 9, 2022 (view filing)Sep 81 dayPaulson Richard A.President and CEOSSale−3.48K$5.23−$18.2K−0.6%623.0K after2 lots
Oct 5, 2022 (view filing)Oct 41 dayPaulson Richard A.President and CEOSSale−3.49K$5.87−$20.5K−0.6%619.5K after
Nov 8, 2022 (view filing)Nov 44 daysPaulson Richard A.President and CEOSSale−3.49K$4.54−$15.9K−0.6%616.0K after
Dec 6, 2022 (view filing)Dec 51 dayPaulson Richard A.President and CEOSSale−3.49K$5.17−$18.0K−0.6%612.5K after
Jan 5, 2023 (view filing)Jan 41 dayPaulson Richard A.President and CEOSSale−3.92K$3.27−$12.8K−0.6%608.6K after
Feb 8, 2023 (view filing)Feb 62 daysPaulson Richard A.President and CEOSSale−3.95K$3.40−$13.4K−0.6%604.7K after
Feb 8, 2023 (view filing)Feb 62 daysMason MichaelEVP, CFO & TreasurerSSale−4.14K$3.40−$14.1K−2.5%164.4K after
Feb 17, 2023 (view filing)Feb 152 daysPoulton StuartEVP, Chief Development OfficerSSale−5.87K$3.19−$18.7K−8.4%64.1K after3 lots
Mar 1, 2023 (view filing)Feb 272 daysMason MichaelEVP, CFO & TreasurerSSale−2.80K$3.04−$8.52K−1.7%161.6K after
Mar 2, 2023 (view filing)Mar 11 dayPaulson Richard A.President and CEOSSale−33.0K$3.03−$100.1K−3.9%823.6K after
Mar 2, 2023 (view filing)Mar 11 dayMason MichaelEVP, CFO & TreasurerSSale−11.2K$3.03−$34.0K−4.4%245.4K after
Mar 2, 2023 (view filing)Mar 11 dayCheng Sohanya RoshanEVP & Chief Commercial OfficerSSale−11.2K$3.03−$34.1K−5.1%210.7K after
Mar 2, 2023 (view filing)Mar 11 dayMano MichaelSVP, General Counsel&SecretarySSale−6.88K$3.03−$20.8K−4.5%146.1K after
Mar 2, 2023 (view filing)Mar 11 dayMitchener StephenSVP, Chief Business OfficerSSale−6.36K$3.03−$19.3K−4.7%128.3K after
Mar 7, 2023 (view filing)Mar 61 dayPaulson Richard A.President and CEOSSale−3.51K$3.16−$11.1K−0.4%820.1K after
Apr 5, 2023 (view filing)Apr 41 dayPaulson Richard A.President and CEOSSale−3.50K$3.97−$13.9K−0.4%816.6K after10b5-1
Apr 24, 2023 (view filing)Apr 204 daysRangwala ReshmaEVP & Chief Medical OfficerSSale−6.77K$4.05−$27.4K−4.1%158.2K after2 lots10b5-1
May 5, 2023 (view filing)May 41 dayPaulson Richard A.President and CEOSSale−3.81K$3.35−$12.7K−0.5%812.8K after10b5-1
Jun 5, 2023 (view filing)Jun 23 daysMason MichaelEVP, CFO & TreasurerSSale−631$2.22−$1.40K−0.3%244.7K after10b5-1
Jun 7, 2023 (view filing)Jun 52 daysPaulson Richard A.President and CEOSSale−3.54K$2.24−$7.92K−0.4%809.3K after10b5-1
Jun 12, 2023 (view filing)Jun 84 daysCheng Sohanya RoshanEVP & Chief Commercial OfficerSSale−1.84K$2.35−$4.32K−0.9%211.5K after10b5-1
Jul 6, 2023 (view filing)Jul 51 dayPaulson Richard A.President and CEOSSale−3.54K$1.72−$6.09K−0.4%805.7K after10b5-1
Aug 1, 2023 (view filing)Jul 284 daysPoulton StuartEVP, Chief Development OfficerSSale−2.85K$1.70−$4.84K−1.8%156.3K after10b5-1